Opinion Statement
Patients with transmural (with ST segment elevation) myocardial infarction should immediately be considered for reperfusion therapy. Fibrinolytic therapy with streptokinase, alteplase, or reteplase should be started within 30 minutes of presentation for patients without bleeding risk. Alternatively, patients at tertiary care hospitals can undergo emergency coronary angioplasty. Other lifesaving pharmacologic interventions include administering aspirin, beta-blockers, and angiotensin-converting enzyme (ACE) inhibitors. Oxygen, morphine sulfate, heparin, and nitroglycerin are also useful. No benefit has been demonstrated for calcium channel blockers, magnesium, or prophylactic lidocaine. Patients need to be closely monitored for conduction abnormalities, arrhythmias, and heart failure.
Similar content being viewed by others
References and Recommended Reading
Ryan TJ, Antman EM, Brooks NH, et al.: 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1999, 34:890–911. This guideline is the definitive reference on treating myocardial infarction.
Bates ER: Acute myocardial infarction. In Conn’s Current Therapy. Edited by Rakel RE. Philadelphia: W.B. Saunders Co.; 1996:307–316.
Yusuf S, Sleight P, Held P, McMahon S: Routine medical management of acute myocardial infarction. Circulation 1990, 82(suppl II):II117-II134.
White HD, Van de Werf FJJ: Thrombolysis for acute myocardial infarction. Circulation 1998, 97:1632–1646. This is the most recent review of advances in thrombolytic therapy.
National Heart Attack Alert Program Coordinating Committee: Emergency department: rapid identification and treatment of patients with acute myocardial infarction. Ann Emerg Med 1994, 23:311–329.
Hennekens CH, Albert CM, Godfried SL, et al.: Adjunctive drug therapy of acute myocardial infarction—evidence from clinical trials. N Engl J Med 1996, 335:1660–1667.
Weaver WD, Simes RJ, Betriu A, et al.: Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction. JAMA 1997, 278:2093–2098. This pooled analysis summarizes data on percutaneous transluminal coronary angioplasty for acute myocardial infarction.
Hochman JS, Sleeper LA, Webb JG, et al. for the SHOCK investigators: Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 1999, 341:625–634.
Mehta RH, Bates ER: Coronary stent implantation in acute myocardial infarction. Am Heart J 1999, 137:603–611.
Bates ER: Platelet glycoprotein IIb/IIIa receptor inhibitor therapy in acute myocardial infarction. Curr Opin Cardiol 1998, 13:274–279.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Turgut, T., Bates, E.R. Acute transmural myocardial infarction. Curr Treat Options Cardio Med 2, 13–18 (2000). https://doi.org/10.1007/s11936-000-0024-z
Issue Date:
DOI: https://doi.org/10.1007/s11936-000-0024-z